Compare GeneDx Holdings Corp (WGS) vs Yum! Brands, Inc. (YUM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GeneDx Holdings Corp vs Yum! Brands, Inc. — how do they compare? GeneDx Holdings Corp trades at $86.53 (market cap $2.56B), while Yum! Brands, Inc. trades at $144.94 (market cap $40.80B). The key difference: Yum! Brands, Inc. is far larger — about 15.9× GeneDx Holdings Corp's market cap, and Yum! Brands, Inc. pays a 2.01% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| WGS | YUM | |
|---|---|---|
Market Cap | $2.56B | $40.80B |
Sector | Technology | Consumer Cyclical |
52-Week High | $167.51 | $168.16 |
52-Week Low | $34.51 | $138.21 |
Enterprise Value | $2.60B | $52.40B |
Dividend Yield | — | 2.01% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
WGS trades at $85.87, down 0.14% today, with a bullish technical signal from moving averages and support at $84. The company reported Q2 2026 revenue of $114.4M, beating estimates, and returned to adjusted profitability early. However, net income remains negative at -$106M for 2026, with high valuation multiples like EV/EBITDA of 161.17. Recent news highlights partnerships and product launches, such as the NPC GenomeComplete initiative with Beren Therapeutics.
Outlook is mixed: strong analyst buy consensus (90.9%) and institutional interest support upside, but profitability challenges and a class action lawsuit pose risks. Revenue growth and operational improvements are key catalysts, yet high debt-to-asset ratios and negative margins require monitoring for sustained recovery.
YUM trades at $149.59, down 0.74% on the day, with a bearish technical signal and neutral oscillators. The company reported revenue of $8.21B and net income of $1.56B in 2025, with a P/E ratio of 18.83. Recent developments include the sale of Pizza Hut for approximately $1.5B to LongRange Capital, with proceeds aimed at debt reduction and share buybacks, alongside a declared $0.75 quarterly dividend.
The outlook is mixed: analyst consensus is a buy with a $173.60 price target, but high debt and a legal investigation pose risks. Earnings have beaten expectations in two of the last three quarters, with Q3 2026 results pending. The stock offers potential upside from strategic refocusing and buybacks, balanced against consumer spending pressures and leverage concerns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →About Yum! Brands, Inc.
Yum Brands is a U.S.-based restaurant operator featuring a portfolio of four brands: KFC (26,930 global units), Pizza Hut (18,380 units), Taco Bell (7,790 units), and The Habit Burger (310 units) at year-end 2021. With $58 billion in 2021 systemwide sales, the firm is the second-largest restaurant company in the world, behind McDonald's ($112.5 billion) but ahead of Restaurant Brands International ($36 billion) and Starbucks ($25 billion). Yum is 98% franchised, with the largest franchisee, Yum China, created via a 2016 spinoff transaction (after which Yum China agreed to pay 3% royalties to Yum Brands in perpetuity). Yum is the newest evolution of Tricon Brands, formerly a division of PepsiCo, and generates the bulk of its revenue from franchise royalties and marketing contributions.
Read more on YUM →
